INBS
INTELLIGENT BIO SOLUTIONS INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.91
−4.50%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$1.31
- Revenue estimate
- $1.4M
Latest reported
- Last report date
- Aug 19, 2026
- EPS actual
- -$1.34
- EPS estimate
- -$1.58
- Revenue actual
- $1.2M
- Revenue estimate
- $1.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -287.9%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 19, 2026 | -$1.58 | -$1.34 | Beat 15.19% | $1.2M |
| May 13, 2026 | $1.40 | -$1.80 | Miss -228.57% | $1.1M |
| Feb 12, 2026 | $0.40 | -$2.82 | Miss -805.00% | $896.8K |
| Nov 12, 2025 | -$1.50 | -$3.50 | Miss -133.33% | $1.1M |
| Aug 15, 2025 | -$1.20 | -$0.37 | Beat 69.17% | $843.9K |
| Feb 13, 2025 | -$3.20 | -$0.50 | Beat 84.38% | $607.5K |
| Nov 7, 2024 | -$0.53 | -$0.70 | Miss -32.08% | $872.3K |
| Sep 19, 2024 | -$0.51 | -$1.34 | Miss -162.75% | $727.8K |
| Feb 9, 2024 | -$3.24 | -$2.07 | Beat 36.11% | $764.1K |
| Aug 24, 2023 | -$20 | -$23 | Miss -15.05% | $443.1K |
| May 11, 2023 | -$2.07 | -$24 | Miss -1077.29% | $457.1K |
| Feb 14, 2023 | — | -$56 | — | $356.7K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026